U.S., Aug. 29 -- ClinicalTrials.gov registry received information related to the study (NCT07793656) titled 'mRNA Therapy to Restore Lymphatic Flow in Secondary Lymphedema' on Aug. 11.
Brief Summary: Lymphedema is a common complication of breast cancer treatment, affecting approximately a quarter of patients. Those affected can have an uncomfortable, unsightly and sometimes functionally impaired limb prone to episodes of superficial infection. The aetiology and pathophysiology of lymphedema in patients with breast cancer appear to be multifactorial and are still not fully understood.Although conservative treatment techniques can be very successful in controlling symptoms, they do not afford a cure. In this situation of unmet medical need, ...